FDA Inspection 1161167 — CFP Acquisitions Inc.
The FDA completed an inspection of CFP Acquisitions Inc. on January 18, 2022 in Tulsa, OK. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- January 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tulsa, OK (United States)